Trials / Sponsors / Senhwa Biosciences, Inc.
Senhwa Biosciences, Inc.
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | CX-4945 in Viral Community Acquired Pneumonia Community-acquired Pneumonia, SARS-CoV-2 -Associated Pneumonia, Influenza With Pneumonia | Phase 2 | 2024-03-20 |
| Completed | A Study of Silmitasertib (CX-4945) in Healthy Subject COVID-19 | Phase 1 | 2022-11-28 |
| Recruiting | Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD Advanced Solid Tumor | Phase 1 | 2021-09-08 |
| Completed | Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate Covid19 | Phase 2 | 2020-11-30 |
| Completed | Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC) Carcinoma, Basal Cell | Phase 1 | 2019-04-16 |
| Completed | Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma Cholangiocarcinoma | Phase 1 / Phase 2 | 2014-06-01 |